Replay, a genomics toolkit startup with roots in San Diego, said Monday that it’s landed $55 million in seed capital to develop technologies for delivering next-generation gene and cell therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback